SMTI
Sanara MedTech Inc

198
Mkt Cap
$164.24M
Volume
47,343.00
52W High
$35.95
52W Low
$18.29
PE Ratio
-4.23
SMTI Fundamentals
Price
$18.38
Prev Close
$18.72
Open
$18.72
50D MA
$20.74
Beta
1.43
Avg. Volume
66,606.64
EPS (Annual)
-$1.14
P/B
26.70
Rev/Employee
$614,698.05
$297.59
Loading...
Loading...
News
all
press releases
Sanara MedTech (NASDAQ:SMTI) Trading Up 0.8% - Here's What Happened
Sanara MedTech (NASDAQ:SMTI) Stock Price Up 0.8% - Here's Why...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates
Evolus (EOLS) delivered earnings and revenue surprises of 0.00% and +0.98%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
Sanara MedTech FY2025 EPS Forecast Boosted by HC Wainwright
Sanara MedTech Inc. (NASDAQ:SMTI - Free Report) - Research analysts at HC Wainwright upped their FY2025 EPS estimates for Sanara MedTech in a research note issued to investors on Monday, January...
MarketBeat·2mo ago
News Placeholder
HC Wainwright Reiterates Buy Rating for Sanara MedTech (NASDAQ:SMTI)
HC Wainwright restated a "buy" rating and issued a $36.00 target price on shares of Sanara MedTech in a report on Monday...
MarketBeat·2mo ago
News Placeholder
Sanara MedTech (NASDAQ:SMTI) Downgraded by Zacks Research to "Hold"
Zacks Research lowered shares of Sanara MedTech from a "strong-buy" rating to a "hold" rating in a research note on Tuesday...
MarketBeat·2mo ago
News Placeholder
Sanara MedTech (NASDAQ:SMTI) Rating Increased to Strong-Buy at Zacks Research
Zacks Research raised shares of Sanara MedTech from a "hold" rating to a "strong-buy" rating in a research note on Monday...
MarketBeat·2mo ago
News Placeholder
Sanara MedTech (SMTI) Upgraded to Strong Buy: Here's What You Should Know
Sanara MedTech (SMTI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2mo ago
News Placeholder
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OSUR files FDA applications seeking approval for two at-home STI tests, advancing decentralized diagnostics; shares gain 3.8% as it targets long-term growth.
Zacks·2mo ago
News Placeholder
Sanara MedTech (NASDAQ:SMTI) Stock Price Up 2% - Here's Why
Sanara MedTech (NASDAQ:SMTI) Shares Up 2% - Still a Buy...
MarketBeat·2mo ago
News Placeholder
Stonebridge Wealth Management LLC Invests $3.40 Million in Sanara MedTech Inc. $SMTI
Stonebridge Wealth Management LLC bought a new position in Sanara MedTech Inc. (NASDAQ:SMTI - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·3mo ago
<
1
2
...
>

Latest SMTI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.